Lupin Limited has informed the Exchange about press release dated 13-Sep-2022 titled Lupin Receives Health Canada Approval for Rymti�� (biosimilar Etanercept).
Lupin Limited has informed the Exchange about press release dated 13-Sep-2022 titled Lupin Receives Health Canada Approval for Rymti�� (biosimilar Etanercept).